Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph G Joyce

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Nature Biotechnology|September 11, 2010
Pushing the envelope on HIV-1 neutralizationJoseph G Joyce, Jan ter Meulen
Bioconjugate Chemistry|December 13, 2007
Amino acid analysis of peptide loading ratios in conjugate vaccines: a comparison of direct electrochemical detection and 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate pre-column derivatization methodsDeborah D Nahas, Jennifer S Palladino, Joseph G Joyce, et al.
Experimental Neurology|September 12, 2009
Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse modelRenee C Gaspar, Stephanie A Villarreal, Nicole Bowles, et al.
Open Forum Infectious Diseases|May 21, 2024
Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming OpportunitiesKristen Feemster, Ulrike K Buchwald, Natalie Banniettis, et al.
The Biochemical Journal|July 11, 2006
Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodiesKausik Chakraborty, Venuka Durani, Edward Roshan Miranda, et al.
Current Topics in Medicinal Chemistry|May 23, 2006
The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's diseaseSusan M Catalano, Elizabeth C Dodson, Darrell A Henze, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Design and Purification of Subunit Vaccines for Prevention of Clostridium difficile InfectionJerzy Karczewski, Jean-Luc Bodmer, James C Cook, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeatDavid C Montefiori, Maria V Filsinger Interrante, Benjamin N Bell, et al.
AIDS Research and Human Retroviruses|December 24, 2008
Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41Renee Hrin, Donna L Montgomery, Fubao Wang, et al.
Vaccine|January 17, 2009
Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeysTong-Ming Fu, Karen M Grimm, Michael P Citron, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Nature Biotechnology|September 11, 2010
Pushing the envelope on HIV-1 neutralizationJoseph G Joyce, Jan ter Meulen
Bioconjugate Chemistry|December 13, 2007
Amino acid analysis of peptide loading ratios in conjugate vaccines: a comparison of direct electrochemical detection and 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate pre-column derivatization methodsDeborah D Nahas, Jennifer S Palladino, Joseph G Joyce, et al.
Experimental Neurology|September 12, 2009
Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse modelRenee C Gaspar, Stephanie A Villarreal, Nicole Bowles, et al.
Open Forum Infectious Diseases|May 21, 2024
Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming OpportunitiesKristen Feemster, Ulrike K Buchwald, Natalie Banniettis, et al.
The Biochemical Journal|July 11, 2006
Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodiesKausik Chakraborty, Venuka Durani, Edward Roshan Miranda, et al.
Current Topics in Medicinal Chemistry|May 23, 2006
The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's diseaseSusan M Catalano, Elizabeth C Dodson, Darrell A Henze, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Design and Purification of Subunit Vaccines for Prevention of Clostridium difficile InfectionJerzy Karczewski, Jean-Luc Bodmer, James C Cook, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 12, 2021
The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeatDavid C Montefiori, Maria V Filsinger Interrante, Benjamin N Bell, et al.
AIDS Research and Human Retroviruses|December 24, 2008
Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41Renee Hrin, Donna L Montgomery, Fubao Wang, et al.
Vaccine|January 17, 2009
Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeysTong-Ming Fu, Karen M Grimm, Michael P Citron, et al.
Pageof 4